티발디 테라퓨틱스TVRD 주가

Wall Street Lunch: BP Slips After Ousting Chairman Albert Manifold Over Governance Concerns

BP (BP) has ousted Chairman Albert Manifold with immediate effect over what the company called “serious concerns” related to governance standards, oversight and conduct.

♻️ 재탕[EFFECT] EFFECT

[EFFECT] EFFECT

Tvardi Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Tvardi Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported net loss was USD 6.8 million compared to USD 9.58 million a...

Tvardi: Q1 Earnings Snapshot

SUGAR LAND, Texas — SUGAR LAND, Texas — Tvardi Therapeutics, Inc. on Friday reported a loss of $6.8 million in its first quarter. The Sugar Land, Texas-based company said it had a loss of 73...

Tvardi Therapeutics Q1 EPS $(0.73) Beats $(0.74) Estimate

Tvardi Therapeutics (NASDAQ:TVRD) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $(0.74) by 1.35 percent. This is a 77.33 percent increase over losses of $(3.22) per share

Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update

Topline results from healthy volunteer study and clinical development strategy for next-generation STAT3 inhibitor, TTI-109, anticipated in June Topline data from Phase 2 trial of TTI-101 in...

[8-K] 중대 사건 — FORM 8-K

[10-Q] 분기 실적 — 10-Q

[POS AM] POS AM — POS AM